Is It Possible To Compare PSA Recurrence-Free Survival After Surgery And Radiotherapy Using Revised ASTRO Criterion-"Nadir + 2"?

Navigation

User login

Upgrade tasks

Check upgrade status
Update modules
Enable maintenance mode
Verify maintenance theme
Verify access to update.php
Disable non-core modules
Verify default theme
Backup current site
Replace Drupal core
Run update.php for core
Download new project versions
Backup current site
Run update.php for modules
Re-enable modules
Check status report

Is It Possible To Compare PSA Recurrence-Free Survival After Surgery And Radiotherapy Using Revised ASTRO Criterion-"Nadir + 2"?

UroToday.com - A lack of randomized trials for radiotherapy (XRT) and radical prostatectomy (RP) make it difficult for patients to compare outcomes. Biochemical recurrence (BR) after RP is defined as an initial level of 0.2ng/ml or greater, with a second confirmatory PSA level of 0.2ng/ml or greater.

Radiology MOC

Navigation

User login

Upgrade tasks

Is It Possible To Compare PSA Recurrence-Free Survival After Surgery And Radiotherapy Using Revised ASTRO Criterion-"Nadir + 2"?